Clinical decision support app helps improve quality of life and longevity for heart failure patients

December 19, 2017, Intermountain Medical Center
A clinical decision support application developed by Intermountain Healthcare researchers that more quickly identifies when heart failure becomes advanced and a heart patient's care needs have changed is successful in helping to improve patient's quality of live and longevity, according to a new study. Credit: Intermountain Medical Center

A clinical decision support application developed by Intermountain Healthcare researchers that more quickly identifies when heart failure becomes advanced and a heart patient's care needs have changed is successful in helping to improve patient's quality of live and longevity, according to a new study.

The new app, which monitors patients' medical tests and health status and promptly notifies clinicians, was developed by a multidisciplinary team of Intermountain Healthcare medical informatics specialists, home health experts, and clinicians from the Intermountain Medical Center Heart Institute in Salt Lake City.

Using the app during the study, researchers found that it led to significantly improved detection of disease advancements. For instance, intervention patients' survival rates increased. More intervention patients were alive compared to a control group at key intervals: 30 days (95% vs. 92%), 60 days (95% vs. 90%), 90 days (94% vs. 87%) and 180 days (92% vs. 84%).

Findings of a study on the effectiveness of the new app are published in the Journal of Cardiac Failure.

"We found that clinical decision support can facilitate the early identification of patients needing advanced heart failure therapy and that its use was associated with significantly more patients visiting specialized heart facilities and longer survival," the study said.

More than six million Americans have heart failure, which means their heart fails to adequately pump blood. That results in an array of symptoms that include fatigue, shortness of breath, swelling, and a fast or erratic heartbeat.

"Heart failure is progressive, and when it becomes advanced, standard therapies are no longer adequate and quality of life plummets," said study lead author R. Scott Evans, MS, PhD, Medical Informatics director at Intermountain Healthcare. "The sooner advanced heart failure is diagnosed and patients begin to receive advanced, specialized treatment, the better they tend to do."

"But patients typically aren't monitored every day and it's hard for doctors to stay up to date on all the research regarding heart failure," he said. "Plus, no single test says the disease has progressed and often patients don't end up in advanced heart failure clinics when they should."

Frustrated by seeing heart failure patients weeks or even months after their symptoms progressed, cardiovascular specialists from the Intermountain Medical Center Heart Institute teamed up with technology experts to create a computer program that would monitor heart failure patients to determine when they need advanced care.

Dr. Evans said the advanced heart failure specialists used their own clinical expertise, along with 2013 American College of Cardiology Foundation/American Heart Association criteria for advanced heart failure, then worked with informatics experts to create and refine three algorithms the computer could apply as it monitored patients daily.

Using heart failure patients in Intermountain Healthcare's Salt Lake County community, the computer first identified those with new echocardiograms that showed a left ventricular ejection fraction of less than 35 percent, which is the cut-off that indicates a patient's condition is deteriorating.

The computer app then begins to monitor their records for relevant signs of progression, such as visits to the hospital or emergency department, lab tests, use of diuretics, technological assistance like left ventricular support, data from EKGs, and more. The mined data was then applied to the algorithms.

When computer monitoring indicates a patient likely has advanced heart failure, the app automatically sends a secure email to the patient's doctors—such as the primary care physician, cardiologist, or the provider who ordered the left ventricular ejection fraction test.

The email includes the recommended therapy and all the relevant information that triggered the alert, and provides a link to a secure Intermountain web-based page that provides further information. It also lists phone numbers and links so doctors can easily connect the patients with advanced specialists.

Doctors who don't want further notification about a specific patient (who is no longer their patient or who has chosen palliative care, for example) are easily removed from the notification.

Negative reaction has been rare, Dr. Evans said. "No one's asked to be removed because it's a nuisance or not valid information," he said. "Instead, more patients were directed into advanced therapy, where their condition and longevity improved compared to the control group."

For controls, the researchers looked at from the previous two years—who would have been the subject of the support app, had it existed, but who were instead retrospectively identified—and compared their outcomes.

Explore further: Reduction in common heart hormone associated with improved outcomes and lower mortality

Related Stories

Reduction in common heart hormone associated with improved outcomes and lower mortality

November 13, 2017
Heart failure patients discharged from the hospital with a reduced level of a common hormone produced by the heart had significantly lower rates of readmission and lower death rates, according to a new study conducted by ...

Heart's pumping function is not an indicator of heart failure survival rates

November 12, 2017
Contrary to popular practice, a measure of the heart's pumping function known as "left ventricular ejection fraction" is not associated with the long-term outcomes of hospitalized heart failure patients, a UCLA-led study ...

Genomic blood test predicts survival rates after surgery for advanced heart failure

December 13, 2017
An experimental blood test developed at UCLA that uses gene activity data from immune cells was 93 percent accurate in predicting survival rates for people with advanced heart failure who had surgery to implant mechanical ...

Research examines benefits of palliative care in heart failure treatment

October 18, 2017
Patients living with heart failure receive palliative care significantly less often than patients with other illnesses, including cancer, despite evidence that such care improves symptom management and quality of life.

Heart failure patients, clinicians have differing perceptions of risk level

August 16, 2017
Physicians identified a majority of patients with advanced heart failure as at high risk for transplant, left ventricular assist device (LVAD) or death while few of those patients considered themselves to be at high risk, ...

Diabetes may have important effects in patients with acute heart failure

June 26, 2017
Researchers have found that patients with acute heart failure and diabetes, compared with those without diabetes, have distinct markers related to inflammation, cardiovascular function, and kidney health.

Recommended for you

Study of two tribes sheds light on role of Western-influenced diet in blood pressure

November 14, 2018
A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg ...

Heart failure patients shouldn't stop meds even if condition improves: study

November 13, 2018
(HealthDay)—There's bad news for heart failure patients with dilated cardiomyopathy who'd like to stop taking their meds.

Bypass beats stents for diabetics with heart trouble: study

November 13, 2018
(HealthDay)—People with both diabetes and multiple clogged heart arteries live longer if they undergo bypass surgery rather than have their blood vessels reopened with stents, according to follow-up results from a landmark ...

Kawasaki disease: One disease, multiple triggers

November 12, 2018
Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography, and international collaborators have evidence that Kawasaki Disease (KD) does not have a single cause. By studying ...

New treatment significantly reduces cardiovascular events when combined with statins

November 12, 2018
Statins are the most commonly used treatment for cardiovascular disease. Despite reducing certain risk factors, if triglyceride levels remain high with use of statins, there is still a significant risk for heart attack, stroke ...

Study: How vitamin D and fish oil affect risk of heart attack, stroke and cancer

November 12, 2018
For years, it's remained an open question: What effects do dietary supplements such as high doses of vitamin D or omega-3 fatty acids derived from fish oil have on the risk of diseases such as heart attack, stroke and cancer? ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.